Nephrotic and nephrotic syndrome every thing please

Reading File

Finding Sources

Reading File

Searching PubMed

"nephrotic syndrome" AND treatment

Searching the Web

nephrotic syndrome vs nephritic syndrome overview 2024

Searching Images

minimal change disease podocyte foot process effacement electron microscopy

Searching Images

crescentic glomerulonephritis histology crescent formation

Searching Images

nephrotic syndrome glomerulus diagram

Searching Images

glomerulonephritis kidney biopsy

Summary : This flowchart outlines the diagnostic strategy for rapidly progressive glomerulonephritis in patients presenting with rapid decline in kidney function, focusing on the use of urinalysis and subsequent steps to differentiate glomerular from non-glomerular causes.

Summary : This flowchart outlines the clinical decision-making process for managing patients with hepatitis C virus (HCV) and severe glomerulonephritis (such as rapidly progressive glomerulonephritis [RPGN] or nephrotic syndrome) who are undergoing direct-acting antiviral (DAA) treatment. It distinguishes between typical and atypical presentations and guides whether to proceed with kidney biopsy and immunosuppression.

Summary : This flowchart outlines the diagnostic strategy for rapidly progressive glomerulonephritis in patients presenting with a rapid decline in kidney function, guiding clinicians through urinalysis findings and subsequent steps to differentiate glomerular from nonglomerular causes.

Nephrotic Syndrome and Nephritic Syndrome

Both are clinical syndromes caused by glomerular disease, but they reflect fundamentally different types of injury to the glomerulus. Nephrotic syndrome results from a non-inflammatory increase in capillary wall permeability to protein (podocyte injury); nephritic syndrome results from inflammatory injury (proliferative/crescentic glomerulonephritis) that damages the capillary wall enough to let blood cells leak through and reduces the filtration rate.

1. Core Definitions

Nephrotic syndrome = proteinuria >3.5 g/24h (or >40 mg/m²/hr in children, urine protein:creatinine ratio >2-3 mg/mg), serum albumin <3.5 g/dL, hyperlipidemia, and clinically apparent edema (National Kidney Foundation Primer on Kidney Diseases, 8e).

Nephritic syndrome = glomerular hematuria (dysmorphic RBCs, RBC casts) plus hypertension, edema, and a reduced GFR (oliguria/azotemia), with proteinuria that is usually sub-nephrotic (Comprehensive Clinical Nephrology, 7th ed., p. 243; National Kidney Foundation Primer).

2. Side-by-Side Comparison

Feature	Nephrotic Syndrome	Nephritic Syndrome
Onset	Insidious	Abrupt
Edema	Marked (++++)	Present but milder (++)
Blood pressure	Usually normal	Raised
Proteinuria	Heavy (++++, nephrotic-range)	Mild-moderate (non-nephrotic)
Hematuria	Absent or minor	Prominent, often with RBC casts
Serum albumin	Low	Normal or mildly reduced
GFR	Usually preserved (unless AKI supervenes)	Often reduced
Mechanism	Podocyte injury, non-inflammatory	Glomerular inflammation, cellular proliferation

(Comprehensive Clinical Nephrology, 7th ed., Table 16.4, p. 243)

Note: these categories are not mutually exclusive. Membranoproliferative GN, lupus nephritis, and some vasculitides can present with mixed nephrotic-nephritic features (Comprehensive Clinical Nephrology, p. 243).

3. NEPHROTIC SYNDROME

Pathophysiology

Injury targets the podocyte (visceral epithelial cell), causing effacement of foot processes and loss of the charge/size barrier that normally restricts albumin filtration. This drives hypoalbuminemia -> reduced oncotic pressure -> edema, and the liver compensates with increased lipoprotein synthesis -> hyperlipidemia (National Kidney Foundation Primer).

Common Causes

Minimal change disease (MCD) - ~15% of adult NS, 70-90% of pediatric NS; mechanism unclear, associated with NSAIDs, thymoma, Hodgkin lymphoma (T-cell mediated hypothesis)
Focal segmental glomerulosclerosis (FSGS)
Membranous nephropathy (MN) - notably higher hypercoagulability risk
Secondary causes: diabetic kidney disease, amyloidosis, lupus, infections (Hep B/C, HIV), drugs, malignancy

(National Kidney Foundation Primer on Kidney Diseases, 8e)

Complications

Iron-deficiency anemia (transferrin loss)
Vitamin D deficiency (vitamin D-binding protein loss)
Hypogammaglobulinemia -> increased infection/sepsis risk
Hypercoagulability -> renal vein thrombosis, especially when proteinuria >10 g/day and albumin <2 g/dL (worst with membranous nephropathy and amyloidosis) - due to urinary loss of protein C, protein S, antithrombin III
Acute kidney injury from intravascular volume depletion

Management

Low-salt, protein-restricted diet (0.8-1 g/kg/day)
ACE inhibitor or ARB (anti-proteinuric cornerstone)
Diuretics for edema, statins for hyperlipidemia, anticoagulation if high thrombotic risk
Disease-specific therapy: corticosteroids are first-line in MCD and childhood NS (prednisone ~60 mg/m²/day or 2 mg/kg/day); steroid-sparing agents (cyclophosphamide, mycophenolate, rituximab, calcineurin inhibitors) for frequently-relapsing or steroid-resistant disease
In children, typical presentations are treated empirically with steroids without biopsy; biopsy is reserved for atypical features (age <1 year, macroscopic hematuria, hypertension, hypocomplementemia, extrarenal symptoms)

(Campbell-Walsh-Wein Urology, 3-Vol Set, p. 458-459; National Kidney Foundation Primer)

4. NEPHRITIC SYNDROME

Pathophysiology

Immune-mediated inflammation (immune complex deposition, complement activation, or leukocyte infiltration) damages the capillary wall, allowing RBCs to pass into urine, and produces hemodynamic changes that reduce GFR -> fluid retention, oliguria, azotemia, and hypertension (partly from renin release by ischemic kidneys) (Robbins, Cotran & Kumar Pathologic Basis of Disease).

Common Causes

Postinfectious/poststreptococcal GN - 1-4 weeks after pharyngitis or impetigo, most common in children 6-10 years; immune complexes with streptococcal antigens
IgA nephropathy - most common primary glomerulopathy worldwide; galactose-deficient IgA1 immune complexes in the mesangium, often triggered by mucosal (respiratory/GI) infection ("synpharyngitic" hematuria); can progress to Henoch-Schonlein purpura/IgA vasculitis
Lupus nephritis (proliferative forms can be nephritic or mixed nephrotic-nephritic)
ANCA-associated (pauci-immune) vasculitis
Anti-GBM disease (Goodpasture syndrome) - can cause pulmonary-renal syndrome
Infective endocarditis, abscess, shunt nephritis

(Comprehensive Clinical Nephrology, Table 16.5; Robbins Pathologic Basis of Disease)

Rapidly Progressive Glomerulonephritis (RPGN)

A severe subtype where kidney function deteriorates over days-weeks. Histologic hallmark is crescentic GN (cellular proliferation in Bowman's space). Causes overlap with the immune-complex, pauci-immune/ANCA, and anti-GBM categories above. This is a medical emergency requiring urgent biopsy and immunosuppression.

Here is a diagnostic approach used clinically for suspected RPGN:

Clinical Picture

Classic presentation (e.g., post-streptococcal GN in children): rapid-onset oliguria, weight gain, generalized edema over days, brown ("cola/tea-colored") urine (not gross clots), proteinuria that is rarely nephrotic-range, normal or near-normal serum albumin, hypertension, and occasionally pulmonary edema without primary cardiac disease.

Management

Directed at the underlying cause rather than a single protocol:

Postinfectious GN: usually supportive (salt/fluid restriction, diuretics, antihypertensives), self-limited in children
IgA nephropathy: ACEi/ARB for proteinuria/BP control; corticosteroids or immunosuppression in progressive disease
ANCA vasculitis / anti-GBM / lupus nephritis / crescentic GN: urgent immunosuppression (high-dose corticosteroids, cyclophosphamide or rituximab), plasma exchange in anti-GBM disease

5. Recent Evidence (PubMed)

Current Cochrane systematic reviews support and refine the classic teaching above:

Corticosteroid therapy remains standard for childhood nephrotic syndrome, though optimal dose/duration is still being refined (Hahn et al., 2024, PMID: 39171624)
For steroid-resistant nephrotic syndrome in children, calcineurin inhibitors and other agents are actively being compared for efficacy (Liu et al., 2025, PMID: 40337980)
Nephrotic syndrome can rarely be paraneoplastic, most often linked to membranous nephropathy in the setting of solid tumors (Liu et al., 2024, PMID: 38965515)

These are consistent with, not contradictory to, the textbook management approach above.

Key Takeaway

Think of it this way: nephrotic = protein leaking out (holes in the filter, no inflammation), nephritic = blood leaking out (inflamed, angry filter). Both can coexist in diseases like membranoproliferative GN, lupus nephritis, and some vasculitides, so clinical classification is a starting point for the differential, not the final diagnosis - biopsy remains the gold standard when the picture is atypical or severe.

Diagnosis

Finding Sources

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

This is a shared conversation. Sign in to Orris to start your own chat.